Gyre Therapeutics posts updated corporate presentation; no material financial disclosures

GYRE THERAPEUTICS, INC.

Presentation titled 'Developing Anti-Fibrotic Therapeutics for Chronic Organ Diseases' made available on company website.
No new financial data, guidance, or clinical trial results disclosed in the filing or exhibit.
Presentation is furnished under Regulation FD; not deemed filed for SEC purposes.
Company continues to focus on fibrotic disease therapies; no changes to strategy announced.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.